Fragile X syndrome epidemiology and demographics: Difference between revisions
Created page with "__NOTOC__ {{Fragile X syndrome}} {{CMG}} == Overview == == Epidemiology and Demographics == The fragile X syndrome has an estimated incidence of 1 in 3600 males and 1 in ..." |
|||
| (4 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
{{CMG}} | {{CMG}} | ||
== Overview == | ==Overview== | ||
The [[prevalence]] of [[female]] [[Carrier|carrie]]<nowiki/>r status has been estimated to be as high as 1 in 130-250 [[population]]; the prevalence of [[male]] carrier status is estimated to be 1 in 250-800 population. However, disease manifestations are seen in lesser number of people. | |||
== Epidemiology and Demographics == | ==Epidemiology and Demographics== | ||
== References == | The [[prevalence]] of Fragile X syndrome is approximately 1 in 5000 men and 1 in 4000-6000 women worldwide, determined by [[Molecular Biology|molecular]] [[assays]]. | ||
Fragile X Syndrome has been diagnosed in approximately 3 percent of boys with significant [[Neurodevelopmental disorders|neurodevelopmenta]]<nowiki/>l [[disorders]]. | |||
==References== | |||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 12:55, 16 September 2021
|
Fragile X syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fragile X syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Fragile X syndrome epidemiology and demographics |
|
Fragile X syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Fragile X syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The prevalence of female carrier status has been estimated to be as high as 1 in 130-250 population; the prevalence of male carrier status is estimated to be 1 in 250-800 population. However, disease manifestations are seen in lesser number of people.
Epidemiology and Demographics
The prevalence of Fragile X syndrome is approximately 1 in 5000 men and 1 in 4000-6000 women worldwide, determined by molecular assays. Fragile X Syndrome has been diagnosed in approximately 3 percent of boys with significant neurodevelopmental disorders.